SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CA3080EBC93DB792BEC73F32E7F4D42B5945E0EB43D3CC8867348C97BF6EC067E4E547B200FAA6C43D56A87248FA85AF>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CA3080EBC93DB792BEC73F32E7F4D42B5945E0EB43D3CC8867348C97BF6EC067E4E547B200FAA6C43D56A87248FA85AF
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CA3080EBC93DB792BEC73F32E7F4D42B5945E0EB43D3CC8867348C97BF6EC067E4E547B200FAA6C43D56A87248FA85AF
http://www.w3.org/2000/01/rdf-schema#comment
"CK1delta inhibition represents a promising strategy for targeted treatment in human breast cancer with Wnt/beta-catenin involvement."
xsd:string
http://purl.uniprot.org/uniprot/#_E9F4A813518295A4977E5322CC1CF60807D023EBB51DD131C45579AC7DC6D128F01F2C689028C9B228FAC75083F2A21F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CA3080EBC93DB792BEC73F32E7F4D42B5945E0EB43D3CC8867348C97BF6EC067E4E547B200FAA6C43D56A87248FA85AF
http://purl.uniprot.org/uniprot/B4DIJ9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CA3080EBC93DB792BEC73F32E7F4D42B5945E0EB43D3CC8867348C97BF6EC067E4E547B200FAA6C43D56A87248FA85AF
http://purl.uniprot.org/uniprot/#_B4DIJ9-mappedCitation-26676609
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CA3080EBC93DB792BEC73F32E7F4D42B5945E0EB43D3CC8867348C97BF6EC067E4E547B200FAA6C43D56A87248FA85AF